Author

L. M. Malone

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:bacteria (other)· 1 Research Focus:benchmarking· 1 Research Focus:database / resource· 1 Assay:metagenomics· 1 Organism:plant (other)· 1 Assay:proteomics· 1

Frequent Co-Authors

P. C. Fineran· 3 shared L. F. Gumy· 2 shared S. A. Jackson· 2 shared S. L. Warring· 2 shared A. R. Pitman· 1 shared C. Garcia-Doval· 1 shared C. Warnecke· 1 shared D. Mayo-Munoz· 1 shared

Activity by Year

2019-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

P. C. Fineran

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Type III CRISPR-Cas provides resistance against nucleus-forming jumbo phages via abortive infection

D. Mayo-Munoz, L. M. Smith, C. Garcia-Doval, L. M. Malone, K. R. Harding, S. A. Jackson, H. G. Hampton, R. D. Fagerlund, L. F. Gumy, P. C. Fineran

The paper shows type III CRISPR-Cas systems provide immunity against jumbo phages by degrading bacterial DNA and disrupting phage replication through an accessory nuclease, leading to abortive infection.

bioRxiv · Jun 20, 2022Microbiology

A lipopolysaccharide-dependent phage infects a pseudomonad phytopathogen and can evolve to evade phage resistance

S. L. Warring, L. M. Malone, J. Jayaraman, R. A. Easingwood, L. A. Rigano, R. A. Frampton, S. B. Visnovsky, S. M. Addison, L. Hernandez, A. R. Pitman, E. Lopez Acedo, T. Kleffmann, M. D. Templeton, M. Bostina, P. C. Fineran

This paper studies a phage that infects a plant pathogen, showing it uses LPS as a receptor and can evolve to bypass bacterial resistance.

bioRxiv · Jun 10, 2022Microbiology

A nucleus-forming jumbophage evades CRISPR-Cas DNA targeting but is vulnerable to type III RNA-based immunity

L. M. Malone, S. L. Warring, S. A. Jackson, C. Warnecke, P. P. Gardner, L. F. Gumy, P. C. Fineran

The paper identifies a jumbophage that evades DNA-targeting CRISPR-Cas systems but is vulnerable to type III RNA-based immunity, revealing the role of nucleus-like structures in immune evasion.

bioRxiv · Sep 25, 2019Microbiology